Gambichler T, Ruhe C, Weyer-Fahlbusch SS, Susok L, et al. Baseline C-reactive protein independently predicts treatment response and survival in metastatic melanoma patients receiving first-line immune checkpoint inhibitors. Eur J Dermatol 2026;36:384-386.
PMID: 42702038